Novel Phenanthridin-6(5H)-one Derivatives As Potent and Selective BET Bromodomain Inhibitors: Rational Design, Synthesis and Biological Evaluation.

Yanle Zhi,Shu Wang,Wenhai Huang,Shenxin Zeng,Meihao Liang,Chixiao Zhang,Zhen Ma,Zunyuan Wang,Zhimin Zhang,Zhengrong Shen
DOI: https://doi.org/10.1016/j.ejmech.2019.06.067
IF: 7.088
2019-01-01
European Journal of Medicinal Chemistry
Abstract:Inhibition of BET family of bromodomain is an appealing intervention strategy for several cancers and inflammatory diseases. This article highlights our work toward the identification of potent, selective, and efficacious BET inhibitors using a structure-based approach focused on improving potency. Our medicinal chemistry efforts led to the identification of compound 24, a novel phenanthridin-6(5H)-one derivative, as a potent (IC50 = 0.24 μM) and selective BET inhibitor with excellent cancer cell lines inhibitory activities and favorable oral pharmacokinetic properties.
What problem does this paper attempt to address?